At a glance
ClinicalIndex Comparison RecordN/ACompleted· 48 enrolled
Drug / intervention
Probiotic +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Efficacy of LR08 in Modulating Gut Microbiota and Improving Metabolic Health in Healthy Adults: A Clinical Study
In Brief
A clinical study evaluating Probiotic and Placebo for Healthy Adults. Completed, enrolled 48 participants across 1 site.
Detailed Summary
Evaluate the efficacy and safety of LR08 as a dietary supplement compared to a placebo in enhancing intestinal health and immune function in healthy adults.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Adults
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2026
Enrollment StartMar 2025
First PostedMar 2025
Primary CompletionMay 2025
Study CompletionJun 2025
TodayJul 2026
First PostedMar 13, 2025
Enrollment StartMar 10, 2025
Primary CompletionMay 30, 2025
Study CompletionJun 30, 2025
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 1.3 years ago
Interventions
Probioticdietary
The trial period of this study lasts for 2 months(8weeks), during which each participant will have 3 visits (at month 0, month 1, andmonth 2).
Placebodietary
The trial period of this study lasts for 2 months(8weeks), during which each participant will have 3 visits (at month 0, month 1, andmonth 2).